Skip to main content

Table 2 KEGG pathway enrichment analysis of the target genes of LINC00968

From: RETRACTED ARTICLE: Long non-coding RNA LINC00968 attenuates drug resistance of breast cancer cells through inhibiting the Wnt2/β-catenin signaling pathway by regulating WNT2

Pathway

p value

Gene

Proteoglycans in cancer

0.005872

TWIST2, DCN, RRAS, THBS1, WNT2

Wnt signaling pathway

0.00678

WNT2

Tyrosine metabolism

0.016454

ALDH3B1, AOX1

Drug metabolism

0.030724

ALDH3B1, AOX1

Viral myocarditis

0.038491

LAMA2, SGCD

Arachidonic acid metabolism

0.041231

CYP2U1, PTGS1

ARVC

0.067227

LAMA2, SGCD

ECM-receptor interaction

0.077424

LAMA2, THBS1

  1. Note: ARVC Arrhythmogenic right ventricular cardiomyopathy, ECM extracellular matrix, LINC00968 long non-coding RNA LINC00968